FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
27 letters match. Newest first.
-
DrugsThomas Brunner Hygiene GmbH
Thomas Brunner Hygiene GmbH's syNeo antiperspirants are unapproved new drugs and were made without adequate manufacturing testing and validation.
High risk -
DrugsLexia LLC
FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.
High risk -
DrugsMiers Laboratories, Ltd
FDA warns Miers Laboratories over manufacturing violations and places import alert on its drugs.
High risk -
DrugsKath Khemicals LLC
FDA: Kath Khemicals, an OTC hand soap maker in Macomb, MI, released drugs without finished-product or glycerin identity testing.
High risk -
FoodVidaslim Co.
Vidaslim Co. dietary supplements are adulterated by CGMP failures and misbranded by label violations.
Medium -
DrugsKenil Healthcare Private Limited
FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.
High risk -
FoodAnti L’Age
FDA warned Anti L'Age over dietary supplements made without required manufacturing standards, records, quality controls, and proper labeling.
Medium -
FoodMother Earth Minerals, Inc.
FDA warns Mother Earth Minerals that its Calcium, Magnesium and Silver are unapproved drugs with disease claims and lack quality controls.
High risk -
DrugsYiling Pharmaceutical Ltd.
FDA warns Yiling Pharmaceutical over manufacturing violations causing cross-contamination risks in finished drugs from shared equipment.
High risk -
DrugsBEO Pharma Inc. dba BEO Pharmaceuticals Inc.
FDA cited BEO Pharma for manufacturing quality violations, including missing identity testing of high-risk drug ingredients and releasing a batch before microbial testing.
High risk -
DrugsMicro Orgo Chem
Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.
High risk -
DrugsLittle Moon Essentials, LLC
FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.
High risk -
DrugsRegenerative Processing Plant, LLC
FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.
High risk -
DrugsIntercos Europe S.p.A
FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.
High risk -
FoodTxsyn Int. LLC
FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.
Medium -
DrugsOmega Tech Labs LLC
Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.
High risk -
FoodCurtis Jacquot dba Pacific BioLogic Co.
Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.
High risk -
DrugsAccra-Pac, Inc. dba Voyant Beauty
Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.
High risk -
DrugsB & J Group
B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.
High risk -
DrugsUltra Chem Labs Corporation
FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.
High risk -
DrugsUrban Electric Power
Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.
High risk -
DrugsEksa Mills S.A. de C.V.
FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.
High risk -
FoodMuscle Feast, LLC
Muscle Feast, LLC lacked ingredient identity and finished-product specifications for dietary supplements, FDA says.
Medium -
DrugsCetylite Industries, Inc.
FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.
High risk -
DrugsIndiana Chem-Port
Indiana Chem-Port API manufacturer cited for CGMP deviations including dirty equipment, unvalidated processes, and cleaning failures.
High risk -
DrugsGulsah Uretim Kozmetik Sanayi Anonim Sirketi
Turkish OTC drug maker Gulsah failed to test its products and ingredients, and FDA blocked its U.S. imports.
High risk -
DrugsNovel Laboratories, Inc. d.b.a LUPIN
FDA warned Lupin's Novel Laboratories over manufacturing violations including equipment cross-contamination and unvalidated temazepam capsules.
High risk